Ilaprazole is a proton pump inhibitor used in the treatment of acid-related gastrointestinal conditions such as gastroesophageal reflux disease, dyspepsia, and peptic ulcer disease. By irreversibly binding… Read more














Ilaprazole is a proton pump inhibitor used in the treatment of acid-related gastrointestinal conditions such as gastroesophageal reflux disease, dyspepsia, and peptic ulcer disease. By irreversibly binding to the H+/K+-ATPase enzyme in gastric parietal cells, this benzimidazole derivative effectively reduces gastric acid secretion. The ilaprazole category includes a comprehensive range of reference standards, including the active pharmaceutical ingredient, identified process-related impurities, and degradation products such as sulfone and desoxy derivatives. Pharmaceutical laboratories utilize these high-quality reference standards for impurity profiling, analytical method validation, and rigorous quality control testing. Furthermore, stable isotope labelled compounds, such as deuterium-labelled analogues, are available to serve as internal standards in mass spectrometry-based bioanalytical assays. These materials are essential for ensuring data accuracy, regulatory compliance, and the reliable quantification of the drug and its metabolites throughout pharmaceutical research and development.